Article

Latest VJCRGS issue focuses on intrascleral haptic fixation

The hour-long issue teaches the viewing ophthalmologist the technique and many modifications of intrascleral haptic fixation, an innovative approach when the capsule has been damage or is absent.

Video journal update: Focusing on intrascleral haptic fixation

The third issue of the 2022 Video Journal of Cataract, Refractive, & Glaucoma Surgery (VJCRGS) is online, taking viewers into an educational journey into the technique that is changing the management of complicated cataract surgery developed by Shin Yamane, MD, from Japan.

The hour-long issue teaches the viewing ophthalmologist the technique and many modifications of intrascleral haptic fixation, an innovative approach when the capsule has been damage or is absent.

Each quarter, a new issue of the video journal is released. The journal provides complimentary access to virtually every cataract society in addition to educating residents, fellows, and private practitioners — allowing access to 38 years of archived years of content.

This year, the video journal celebrates its 38th year of providing quality of education to anterior segment surgeons around the world, according to its founder and editor Robert H. Osher, MD. Osher is Professor of Ophthalmology, University of Cincinnati College of Medicine, and Medical Director Emeritus, Cincinnati Eye Institute in Cincinnati, Ohio.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
(Image credit: Ophthalmology Times) ASCRS 2025: Jason Bacharach, MD, on early-onset efficacy with perfluorohexyloctane in dry eye
(Image credit: Ophthalmology Times) CCOI's new CEO Malvina Eydelman, MD, outlines her mission and vision for the organization
CIME 2025: Neda Shamie, MD, on expanding options in pharmacological presbyopia management
© 2025 MJH Life Sciences

All rights reserved.